GENB-OAC Study Insights from Gabrielle Sarlon and The Team
RPTH Journal shared on LinkedIn:
”New data about abnormal uterine bleeding under oral anticoagulants,
Abnormal uterine bleeding (AUB) is a frequent and underestimated complication in women of reproductive age receiving anticoagulation for venous thromboembolism.
Key findings from the GENB-OAC study (multicenter, national cohort):
AUB was significantly more frequent in women on oral anticoagulants compared with controls
Rates were higher with rivaroxaban and vitamin K antagonists compared with apixaban
Clinically relevant non-major bleeding and heavy menstrual bleeding were more common with rivaroxaban
Quality of life was reduced in women receiving anticoagulation, with no significant difference between oral anticoagulant groups”
Title: Prevalence of abnormal uterine bleeding and quality of life after venous thromboembolism by oral anticoagulant use: the GENB-OAC Study
Authors: Gabrielle Sarlon-Bartoli, Barbara Leclercq, Nathalie Trillot, Isabelle Mahé, Marie Daoud-Elias, Andrea Buchmuller, Geraldine Poenou, Antoine Elias, Jean Noel Poggi, Francis Couturaud, Noemie Resseguier, Martin Postzich, Lylia Hammoudi, Yasmine Benredouane, Florence Bretelle, Louisa Goumidi, Pierre Suchon, Sarah Jidal, Antonia Perez-Martin, Clementine Rousselin, Isabelle Quere, Sandrine Mestre, Marie Antoinette Sevestre, Simon Soudet, Laurent Bertoletti, Sophie Susen, Pierre Emmanuel Morange
Read the Full Article on RPTH Journal/PubMed
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 04:54Saneha Anjum Shaik: What Every Clinician Should Know Before Ordering Blood Tests
-
Jul 5, 2026, 04:37Mathis Richter: How The Bone Marrow Responds To Myocardial Infarction Predicts Clinical Outcome
-
Jul 5, 2026, 02:45Marie Luise Hütter-Krönke: Can a Short Course of BCMA-Targeted Therapy Induce Long-Term Remission in Refractory Autoimmune Disease?
-
Jul 5, 2026, 02:24Shreya Agarwa: Transforming Care For Adolescents With Heavy Menstrual Bleeding
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins